Ranokhon Igamberdieva

30 та иш

Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

1. #1800 Cardiorenal relationships: correlation analysis of the effect of metabolic syndrome components on renal and cardiac function in heart failure patients with mid-range ejection fraction

   Музаффар Илхомжон Асомов, Gulchehra Atakhodjayeva, Olimkhon Sharapov +3

   МақолаDiabetes Management and ResearchNephrology Dialysis Transplantation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009283

2. #1857 The efficacy and safety of using various combinations of antithrombotic therapy in patients with AF and ESKD undergoing program hemodialysis

   Ranokhon Igamberdieva, Sherzod Abdullaev

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009284

3. Abstract 4369641: The impact of renal injury markers on bleeding risk in chronic kidney disease and atrial fibrillation patients receiving rivaroxaban

   Ranokhon Igamberdieva, Sherzod Abdullaev

   МақолаAcute Kidney Injury ResearchCirculation20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.009540

4. Association of Kidney Damage Markers with Bleeding Risk in CKD and Atrial Fibrillation During Rivaroxaban Treatment

   Ranokhon Igamberdieva, Sherzod Abdullaev

   МақолаAtrial Fibrillation Management and OutcomesJournal of the American Society of Nephrology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.013726

5. WCN26-7478 ASSOCIATION BETWEEN URINARY TUBULAR INJURY MARKERS AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE RECEIVING RIVAROXABAN

   Ranokhon Igamberdieva, Sherzod Abdullaev

   МақолаAcute Kidney Injury ResearchKidney International Reports20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.008621